Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits
- PMID: 26054671
- DOI: 10.1016/j.biopha.2015.03.007
Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits
Abstract
The administration of statin might increase the risk of new-onset diabetes in hypercholesterolemic patients based on the recent clinical evidence. However, the causal relationship must be clarified and confirmed in animal experiments. Therefore, we mimicked hypercholesterolemia by feeding rabbits a high-cholesterol diet (HCD) and performed 16 weeks of atorvastatin administration to investigate the effect of statin on glucose metabolism. The intravenous glucose tolerance test showed that plasma glucose levels in the statin-treated rabbits were consistently higher and that there was a slower rate of glucose clearance from the blood than in HCD rabbits. The incremental area under the curve for glucose in the statin-treated rabbits was also significantly larger than in the HCD rabbits. However, there was no significant difference between the two groups in the intravenous insulin tolerance test. The glucose-lowering ability of exogenous insulin was not impaired by statin treatment in hypercholesterolemic rabbits. The administration of a single dose of statin did not affect glucose metabolism in normal rabbits. The statin also significantly increased the levels of high-density lipoprotein cholesterol, alanine aminotransferase and aspartate transaminase and decreased plasma levels of total cholesterol, triglycerides and low-density lipoprotein cholesterol in the hypercholesterolemic rabbits, whereas it did not affect plasma levels of glucose and insulin. The current results showed that atorvastatin treatment resulted in a significant delay of glucose clearance in hypercholesterolemic rabbits, and this rabbit model could be suitable for studying the effects of statin on glucose metabolism.
Keywords: Atorvastatin; Glucose tolerance; Hypercholesterolemia; Rabbits.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.Lipids Health Dis. 2015 Jul 29;14:82. doi: 10.1186/s12944-015-0083-5. Lipids Health Dis. 2015. PMID: 26220196 Free PMC article.
-
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.Cardiovasc Ther. 2015 Oct;33(5):282-7. doi: 10.1111/1755-5922.12143. Cardiovasc Ther. 2015. PMID: 26146893 Clinical Trial.
-
Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia.Fundam Clin Pharmacol. 2015 Aug;29(4):362-70. doi: 10.1111/fcp.12125. Epub 2015 Jun 5. Fundam Clin Pharmacol. 2015. PMID: 25982284
-
A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017. Clin Ther. 2008. PMID: 18640465 Clinical Trial.
-
Atorvastatin.2021 Dec 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2021 Dec 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643561 Free Books & Documents. Review.
Cited by
-
Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet.Sci Rep. 2017 May 19;7(1):2169. doi: 10.1038/s41598-017-02080-w. Sci Rep. 2017. PMID: 28526884 Free PMC article.
-
Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice.Mol Med Rep. 2018 Sep;18(3):2780-2788. doi: 10.3892/mmr.2018.9239. Epub 2018 Jul 3. Mol Med Rep. 2018. PMID: 30015940 Free PMC article.
-
Geranylgeranyl pyrophosphate depletion by statins compromises skeletal muscle insulin sensitivity.J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2697-2711. doi: 10.1002/jcsm.13061. Epub 2022 Aug 12. J Cachexia Sarcopenia Muscle. 2022. PMID: 35961942 Free PMC article.
-
The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function.Front Microbiol. 2022 Feb 2;12:797062. doi: 10.3389/fmicb.2021.797062. eCollection 2021. Front Microbiol. 2022. PMID: 35185821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical